SRNE logo

Sorrento Therapeutics, Inc. (SRNE)

Profile

Full Name

Sorrento Therapeutics, Inc.

Ticker

NASDAQ: SRNE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 19, 2007

Indexes

Not included

Website

https://www.sorrentotherapeutics.com

Employees

949

Key Details

Price

$0.01(+195.24%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$62.84M(+18.78% YoY)

Annual EPS

-$1.37(+5.52% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.01
    SRNE price is $0.01

    30-Day Relative Volume

    0.88
    SRNE 30-day relative volume is 0.88

    Price Performance

    Price Today change

    +195.24%
    SRNE price is up +195.24% today

    Price YTD change

    +1140%
    SRNE price is up +1140% since January 1st

    Price 1-year change

    -31.11%
    SRNE price is down -31.11% year-on-year

    Price 3-year change

    -99.7%
    SRNE price is down -99.7% over the past 3 years

    Price Range

    Price All-time high

    $167.50K
    SRNE price is currently -100.00% below its historical high of $167.50 thousand

    Price 3-year low

    $0.00
    SRNE price is currently +6100.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.42M
    SRNE market capitalization is $3.42 million

    Market cap 3-year change

    -99.63%
    SRNE market capitalization is down -99.63% over the past 3 years

    Market cap All-time high

    $4.63B
    SRNE market capitalization is currently -99.93% below its historical high of $4.63 billion

    Market cap sector rank

    7.3%
    SRNE market capitalization is higher than 7.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    SRNE shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +22.52%
    SRNE shares outstanding is up +22.52% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -1.44
    SRNE beta is -1.44

    200-day SMA

    $0.00
    SRNE price is currently +287.50% above its 200-day simple moving average

    50-day SMA

    $0.00
    SRNE price is currently +210.00% above its 50-day simple moving average

    RSI

    47.37
    SRNE 14-day relative strength index is 47.37

    Volume

    0.88
    SRNE 30-day relative volume is 0.88

    ATR

    $0.00
    SRNE average true range is $0.00

    10-day Historical Volatility

    1238.83%
    SRNE 10-day historical volatility is 1238.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $62.84M
    SRNE annual revenue is $62.84 million

    Revenue Analysts estimate

    $57.53M
    SRNE annual revenue is currently +9.23% higher than the consensus analysts' forecast

    Revenue 1-year change

    +18.78%
    SRNE annual revenue is up +18.78% year-on-year

    Revenue Sector rank

    64.17%
    SRNE annual revenue is higher than 64.17% of companies in Healthcare sector

    EPS

    EPS

    -$1.37
    SRNE annual earnings per share is -$1.37

    EPS Analysts estimate

    -
    SRNE annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +5.52%
    SRNE annual earnings per share is up +5.52% year-on-year

    EPS Sector rank

    44.56%
    SRNE annual earnings per share is higher than 44.56% of companies in Healthcare sector

    Profit

    Gross profit

    $25.06M
    SRNE annual gross profit is $25.06 million

    Gross margin

    39.88%
    SRNE annual gross profit margin is 39.88%

    Operating profit

    -$378.50M
    SRNE annual operating income is -$378.50 million

    Operating margin

    -602.33%
    SRNE annual operating profit margin is -602.33%

    Net income

    -$577.76M
    SRNE annual net profit is -$577.76 million

    Net margin

    -919.42%
    SRNE annual net profit margin is -919.42%

    Expenses

    Total expenses

    $635.68M
    SRNE annual total expenses is $635.68 million

    Operating expenses

    $403.56M
    SRNE annual total operating expenses is $403.56 million

    Cost of goods sold

    $37.78M
    SRNE annual cost of goods sold is $37.78 million

    Selling, general & administrative expenses

    $182.34M
    SRNE annual SGA is $182.34 million

    Depreciation and amortization

    $17.48M
    SRNE annual depreciation & amortization is $17.48 million

    Interest expense

    $0.00
    SRNE annual interest expense is $0.00

    Income tax

    -$2.42M
    SRNE annual income tax is -$2.42 million

    EBIT & EBITDA

    EBIT

    -$553.17M
    SRNE annual earnings before interest & taxes is -$553.17 million

    EBITDA

    -$361.03M
    SRNE annual EBITDA is -$361.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $514.49M
    SRNE annual total assets is $514.49 million

    Non current assets

    $376.47M
    SRNE annual long term assets is $376.47 million

    Current assets

    $96.37M
    SRNE annual total current assets is $96.37 million

    Cash and cash equivalents

    $49.98M
    SRNE annual cash & cash equivalents is $49.98 million

    Accounts receivable

    $24.47M
    SRNE annual accounts receivable is $24.47 million

    Inventory

    $9.98M
    SRNE annual inventory is $9.98 million

    Liabilities

    Total liabilities

    $536.16M
    SRNE annual total liabilities is $536.16 million

    Long term liabilities

    $103.90M
    SRNE annual total long term liabilities is $103.90 million

    Current liabilities

    $327.92M
    SRNE annual total current liabilities is $327.92 million

    Accounts payable

    $47.52M
    SRNE annual accounts payable is $47.52 million

    Debt

    Total debt

    $134.50M
    SRNE annual total debt is $134.50 million

    Total debt 1-year change

    -43.39%
    SRNE annual total debt is down -43.39% year-on-year

    Long term debt

    $104.34M
    SRNE annual long term debt is $104.34 million

    Short term debt

    $30.17M
    SRNE annual short term debt is $30.17 million

    Equity & Capital

    Shareholders equity

    -$18.61M
    SRNE annual stockholders equity is -$18.61 million

    Book value

    -$18.61M
    SRNE annual book value is -$18.61 million

    Retained earnings

    -$1.96B
    SRNE annual retained earnings is -$1.96 billion

    Working capital

    -$231.55M
    SRNE annual working capital is -$231.55 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$293.86M
    SRNE annual cash flow from operations is -$293.86 million

    Cash from operations 1-year change

    -4.27%
    SRNE annual cash flow from operations is down -4.27% year-on-year

    Cash from investing

    -$28.52M
    SRNE annual cash flow from investing activities is -$28.52 million

    Cash from investing 1-year change

    -135.72%
    SRNE annual cash flow from investing activities is down -135.72% year-on-year

    Cash from financing

    $311.72M
    SRNE annual cash flow from financing activities is $311.72 million

    Cash from financing 1-year change

    +71.9%
    SRNE annual cash flow from financing activities is up +71.9% year-on-year

    CAPEX

    CAPEX

    $13.66M
    SRNE annual capital expenditures is $13.66 million

    CAPEX 1-year change

    +53.95%
    SRNE annual capital expenditures is up +53.95% year-on-year

    Free Cash Flow

    Free cash flow

    -$307.51M
    SRNE annual free cash flow is -$307.51 million

    Free cash flow 1-year change

    -5.79%
    SRNE annual free cash flow is down -5.79% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    39.88%
    SRNE annual gross profit margin is 39.88%

    Operating margin

    -602.33%
    SRNE annual operating profit margin is -602.33%

    Net margin

    -919.42%
    SRNE annual net profit margin is -919.42%

    ROA & ROE

    ROA

    -89.76%
    SRNE annual return on assets is -89.76%

    ROE

    -2046.61%
    SRNE annual return on equity is -2046.61%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SRNE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SRNE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.02
    SRNE price to book ratio is -0.02

    PB ratio Sector rank

    14.8%
    SRNE price to book ratio is higher than 14.8% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.05
    SRNE price to sales ratio is 0.05

    PS ratio Sector rank

    3.44%
    SRNE price to sales ratio is higher than 3.44% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $130.38M
    SRNE enterprise value is $130.38 million

    Enterprise value Sector rank

    52.34%
    SRNE enterprise value is higher than 52.34% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.39
    SRNE EV/EBITDA is -0.39

    EV/EBITDA Sector rank

    52.26%
    SRNE EV/EBITDA is higher than 52.26% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.29
    SRNE annual current ratio is 0.29

    Quick ratio

    0.26
    SRNE annual quick ratio is 0.26

    Leverage

    Debt to equity

    -7.23
    SRNE annual debt to equity ratio is -7.23

    Interest coverage ratio

    -
    SRNE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    SRNE piotroski f-score is 3

    Altman Z-Score

    -9.29
    SRNE altman z-score is -9.29

    Analyst ratings

    Recent major analysts updates

    Nov 2, 22 Cantor Fitzgerald
    Overweight
    Mar 25, 22 HC Wainwright & Co.
    Buy
    Aug 9, 21 HC Wainwright & Co.
    Buy
    Jan 21, 21 Alliance Global Partners
    Buy
    Jul 31, 20 HC Wainwright & Co.
    Buy
    May 26, 20 Dawson James
    Buy
    Mar 30, 20 HC Wainwright & Co.
    Buy
    Mar 30, 20 H.C. Wainwright
    Buy
    Oct 7, 19 JMP Securities
    Market Outperform
    Mar 20, 19 B. Riley Securities
    Buy

    Institutional Ownership

    Screeners with SRNE included

    Stocks cheaper than 1 dollar
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Sorrento Therapeutics, Inc.?
    • Does Sorrento Therapeutics, Inc. pay dividends?
    • What sector is Sorrento Therapeutics, Inc. in?
    • What industry is Sorrento Therapeutics, Inc. in?
    • What country is Sorrento Therapeutics, Inc. based in?
    • When did Sorrento Therapeutics, Inc. go public?
    • Is Sorrento Therapeutics, Inc. in the S&P 500?
    • Is Sorrento Therapeutics, Inc. in the NASDAQ 100?
    • Is Sorrento Therapeutics, Inc. in the Dow Jones?
    • When was Sorrento Therapeutics, Inc.'s last earnings report?
    • When does Sorrento Therapeutics, Inc. report earnings?

    What is the ticker symbol for Sorrento Therapeutics, Inc.?

    The ticker symbol for Sorrento Therapeutics, Inc. is NASDAQ:SRNE

    Does Sorrento Therapeutics, Inc. pay dividends?

    No, Sorrento Therapeutics, Inc. does not pay dividends

    What sector is Sorrento Therapeutics, Inc. in?

    Sorrento Therapeutics, Inc. is in the Healthcare sector

    What industry is Sorrento Therapeutics, Inc. in?

    Sorrento Therapeutics, Inc. is in the Biotechnology industry

    What country is Sorrento Therapeutics, Inc. based in?

    Sorrento Therapeutics, Inc. is headquartered in United States

    When did Sorrento Therapeutics, Inc. go public?

    Sorrento Therapeutics, Inc.'s initial public offering (IPO) was on January 19, 2007

    Is Sorrento Therapeutics, Inc. in the S&P 500?

    No, Sorrento Therapeutics, Inc. is not included in the S&P 500 index

    Is Sorrento Therapeutics, Inc. in the NASDAQ 100?

    No, Sorrento Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Sorrento Therapeutics, Inc. in the Dow Jones?

    No, Sorrento Therapeutics, Inc. is not included in the Dow Jones index

    When was Sorrento Therapeutics, Inc.'s last earnings report?

    Sorrento Therapeutics, Inc.'s most recent earnings report was on November 22, 2023

    When does Sorrento Therapeutics, Inc. report earnings?

    The date for Sorrento Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page